{"disease":{"id":"pi3k-akt-mtor-pathway-mutation","name":"pi3k akt mtor pathway mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05054166","title":"Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study","phase":"","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}